The papers in this collection are drawn from a symposium held in Vienna in December 2010. Organised by the Institute for European Tort Law and the Chicago-Kent Law Review, in collaboration with the European Centre of Tort and Insurance Law, the conference drew together legal experts from 14 national or regional systems across six continents. Medical malpractice and compensation for medical injuries are issues which regularly create tension and innovation in national legal systems but the analysis of these areas is often limited to national audiences. This study examines the issues in a uniquely global context, demonstrating the breadth of approaches currently taken around the world and revealing key areas of tension and the likely direction of future developments. Wherever possible, the analysis is supported by reference to empirical data. The 14 legal systems covered in the collection are Austria, Brazil, Canada, China, France, Germany, Italy, Japan, New Zealand, Poland, Scandinavia, South Africa, the United Kingdom and the United States. A general comparative introduction completes the collection.
Inhaltsverzeichnis
1;Medical Malpractice and Compensation in Global Perspective: Introduction;19 1.1;I. Issues Addressed;20 1.1.1;A. Overall Scheme;20 1.1.2;B. Details of the Applicable Liability and Compensation Systems;21 1.1.3;C. Empirical Data;22 1.1.4;D. Attitudes, Concerns, and Prospects;22 1.2;II. Aims;22 2;Medical Malpractice in Austria;25 2.1;Introduction;25 2.2;I. The Insurance Framework;26 2.2.1;A. Social Insurance in Austria;26 2.2.2;B. The Role of Private Insurance;27 2.2.2.1;1. First-Party Insurance;27 2.2.2.2;2. Liability Insurance;28 2.3;II. The Regulatory Framework;28 2.3.1;A. Professional Law;28 2.3.2;B. Criminal Law;29 2.3.3;C. Contract Law;30 2.3.4;D. Tortious and Contractual Liability;31 2.3.4.1;1. Tortious and Contractual Liability Not Mutually Exclusive;31 2.3.4.2;2. Tort Law in General;32 2.3.4.3;3. Damage;32 2.3.4.4;4. Causation;32 2.3.4.5;5. Wrongfulness and Fault;35 2.3.4.6;6. Multiple Persons Involved;36 2.3.4.7;7. Informed Consent;39 2.3.4.8;8. Remedies;42 2.4;III. Compensation claims in practice;46 2.4.1;A. General Remarks;46 2.4.2;B. Patient Advocacies;47 2.4.3;C. Conciliation Bodies;48 2.4.4;D. Compensation Funds;49 2.4.5;E. Outlook;50 3;A Bridge over troubled Waters: The Development of Medical Malpractice Litigation in Brazil;53 3.1;Introduction;53 3.2;I. The Brazilian Legal System;57 3.3;II. The Structure of the Brazilian Legal System;58 3.4;III. The influence of the Consumers Defense Code;61 3.4.1;A. Informed Consent, the Duty to Inform, and Informed Choice;63 3.4.2;B. Moral Damages and the Inversion of the Burden of Proof As Patients Basic Rights;67 3.5;IV. The Changes Brought by the New Civil Code;68 3.6;Conclusion;70 4;Canadian Medical Malpractice Law in 2011: Missing the Mark on Patient Safety;73 4.1;Introduction;73 4.2;I. The Canadian Malpractice Context;75 4.2.1;rvice Delivery, Regulation and Liability Insurance;77 4.3;II. State and Quality of the Canadian Health Care System;78 4.3.1;A. Medical Malpractice in the Domain of Privately Financed Ca
re;84 4.4;III. Redressing Adverse Events through the Courts;85 4.4.1;A. Canadian Medical Malpractice Liability in Context;87 4.4.2;B. Empirical Trends on Medical Liability Claims;88 4.4.3;C. Black Letter of Canadian Tort Law;90 4.4.3.1;1. Battery by Physicians;91 4.4.3.2;2. Negligence by Physicians;91 4.4.3.3;3. Hospital Liability;99 4.4.3.4;4. Government Liability;101 4.4.3.5;5. Damages;102 4.4.3.6;6. Ongoing Issues and Avenues of Reform;104 4.5;IV. Preventing Adverse Events: Professional and System Reform;105 4.5.1;A. Reforms at the Level of the Professions;106 4.5.1.1;1. Alternative Complaint Mechanisms;106 4.5.1.2;2. Revalidation/Recertification;107 4.5.1.3;3. Apology Legislation;108 4.5.2;B. Systemic Reforms;109 4.5.2.1;1. Accreditation of Facilities;109 4.5.2.2;2. Canadian Patient Safety Institute;110 4.5.2.3;3. Improved Information Gathering and Dissemination;110 4.6;Conclusion;112 5;Yangge Dance: the Rhythm of Liability for Medical Malpractice in the Peoples Republic of China;115 5.1;Introduction;115 5.2;I. The Wider Healthcare Context;117 5.3;II. The Early P.R. China: Medical Services as Social Welfare (19491987);120 5.4;III. The Administrative Liability Regime;123 5.4.1;A. The Medical Accident Rules 1987;123 5.4.1.1;1. Context;123 5.4.1.2;2. Main Features of the Administrative Liability Regime, 19872002;124 5.4.2;B. The Medical Accident Regulations 2002;126 5.4.2.1;1. Context;126 5.4.2.2;2. Main Features of the Administrative Liability Regime, 2002 onwards;126 5.5;IV. The Tort Liability Regime;129 5.5.1;A. Recourse to the General Principles of Civil Liability;129 5.5.2;B. Elements of the Tort Liability Regime;131 5.5.2.1;1. Cause of Action;131 5.5.2.2;2. Burden of Proof;131 5.5.2.3;3. The Identification Process;132 5.5.2.4;4. Assessment of Damages;133 5.5.3;C. Effect on the Administrative Liability Regime;134 5.6;V. Reform of Medical Liability under the Tort Liability Law of 2009;135 5.6.1;A. Antecedents;135 5.6.1.1;1. Increasing Disputes between Doctors a
nd Patients;135 5.6.1.2;2. Concerns about Defensive Medical Treatments;136 5.6.1.3;3. The Chaos Resulting from the Dual Dystem of Medical Liability;137 5.6.2;B. Legislative History;138 5.6.3;C. Four Dimensions of the TLL;139 5.6.3.1;1. Basis of the Cause of Action;139 5.6.3.2;2. Burden of Proof;142 5.6.3.3;3. The Identification Procedure;144 5.6.3.4;4. Assessment of Damages;144 5.7;VI. Another Step Backwards on Its Way?;145 5.8;Conclusion;148 6;Medical Malpractice and Compensation in France;149 6.1;Part I: The French Rules of Medical Liability since the Patients Rights Law of March 4, 2002;149 6.1.1;Introduction;149 6.1.2;I. General Conditions of Medical Liability;152 6.1.2.1;A. Facts Likely to Justify the Physicians Responsibility;153 6.1.2.1.1;1. Liability Based on Fault;154 6.1.2.1.2;2. Strict Liability;161 6.1.2.2;B. The Causal Link;166 6.1.2.2.1;1. Causation Criterion;166 6.1.2.2.2;2. Causation Proof;167 6.1.2.3;C. The Victims Harm;172 6.1.3;II. Administration and Adjudication of claims based on liability rules;174 6.1.3.1;A. Adjudication Through Conciliation Commissions;175 6.1.3.2;B. Adjudication Through Courts;177 6.2;Part II: Compensation Based on National Solidarity;181 6.2.1;Introduction;181 6.2.2;I. Typology of Cases Covered by National Solidarity;182 6.2.2.1;A. Medical Hazards;182 6.2.2.2;B. Hospital-Acquired Infections;184 6.2.2.3;C. Blood Transfusions Infections;185 6.2.2.3.1;1. HIV Infection;185 6.2.2.3.2;2. Hepatitis C Infection;186 6.2.2.3.3;3. Additional Grounds;186 6.2.3;II. Administration and Adjudication of Claims Based on National Solidarity;187 6.2.3.1;A. Administrated Claims;187 6.2.3.2;B. Procedural Routes to ONIAM;189 6.2.3.3;C. Adjudication Proceedings in Front of ONIAM;191 6.2.3.4;D. Regulatory Principles Applying to Rights of Recourse;192 6.2.4;III. Awarded Compensation;193 7;Medical Malpractice and Compensation in Germany;197 7.1;Introduction;197 7.2;I. The Potential Legal Consequences of Medical Injury;199 7.2.1;A. Criminal Law;199 7.
2.2;B. Professional and Disciplinary Sanctions;200 7.2.3;C. Fault-Based Compensation in Private Law;201 7.2.4;D. Strict Liability and No-Fault Compensation for Medical Product Injury;204 7.2.5;E. Social Security, Insurance, and Subrogation Issues;205 7.3;II. The System of Private Law Compensation;207 7.3.1;A. Treatment Malpractice Claims;207 7.3.1.1;1. Faulty Treatment;207 7.3.1.2;2. Causation;210 7.3.1.3;3. Proof Issues;211 7.3.2;B. Disclosure Malpractice Claims;214 7.3.2.1;1. Background;214 7.3.2.2;2. Standard of Disclosure;215 7.3.2.3;3. Causation;216 7.3.3;C. Damages and Liability Insurance Issues;217 7.3.4;D. The Medical Arbitration Boards;219 7.4;III. Assessment of the Current Situation;220 7.4.1;A. Empirical Data;220 7.4.2;B. Evaluation of the Private Law Redress Rules;223 7.4.3;C. Patient Safety Initiatives;225 7.5;Conclusion;226 7.6;Addendum;227 8;Medical Malpractice: The Italian Experience;229 8.1;Introduction;229 8.2;I. The Problematic Nature of Medical Liability;231 8.3;II. The Assignment of the Burden of Proof Between Parties;239 8.3.1;A. Proving Fault;239 8.3.2;B. Proving Causation-In-Fact;244 8.3.3;C. Proving Causation Under the Criminal Law and Under the Civil Law;247 8.3.4;D. The Role of Informed Consent;250 8.4;Conclusion;253 9;The Law of Medical Misadventure in Japan;257 9.1;Introduction;257 9.2;I. Prosecutions and Their Consequences;260 9.2.1;A. Prosecutions in Medical Cases;260 9.2.2;B. Response by the Health Ministry and the Medical Profession;264 9.2.3;C. One Prosecution Too Many: The Medical Professionals Counterattack and the String of Acquittals;267 9.3;II. Civil Liability;269 9.3.1;A. Substantive Law of Medical Malpractice;270 9.3.1.1;1. Theories of Recovery;270 9.3.1.2;2. Standard of Care;271 9.3.1.3;3. Level of Proof;272 9.3.1.4;4. Informed Consent and Related Actions;275 9.3.1.5;5. Damages;276 9.3.2;B. Key Aspects of Procedural Law and Practice;278 9.3.2.1;1. In General;278 9.3.2.2;2. Discovery of Peer Review Findings;279 9.3.2.3;3. Jud
icial Administration Reforms;280 9.3.2.4;4. Settlement Practices, Overall Claiming Levels, and Malpractice Insurance Premiums;281 9.3.2.5;5. Plaintiffs Attorney Fees and Court Filing Fees;285 9.4;III. The No-Fault Compensation System for Obstetrical Injury;286 9.5;Conclusion;289 9.6;Addendum;291 10;Treatment Injury in New Zealand;293 10.1;Introduction;293 10.2;I. The New Zealand Accident Compensation Scheme;294 10.2.1;A. The Woodhouse Report;294 10.2.2;B. Implementation;296 10.2.3;C. Developments to 2010;297 10.2.4;D. Relationship with the Common Law;301 10.2.5;E. Cover;303 10.2.5.1;1. Categories of Cover;303 10.2.5.2;2. Personal Injury;304 10.2.5.3;3. Residual Actions for Damages;305 10.2.6;F. Claimants;306 10.2.7;G. Benefits;306 10.2.8;H. Claims Process;308 10.2.9;I. Funding;309 10.2.10;J. Administration;310 10.3;II. Medical Injuries;310 10.3.1;A. Cover;313 10.3.2;B. Treatment Injury;314 10.3.2.1;1. Proof of Cause;314 10.3.2.1.1;a. Atkinson and Ambros;315 10.3.2.1.2;b. Modification of Ordinary Rules?;319 10.3.2.2;2. Nature of Treatment Injury;322 10.3.2.3;3. Treatment Injury in Operation;325 10.3.2.4;4. Costs;328 10.3.3;C. Professional Accountability;329 10.3.3.1;1. Reporting of Medical Risks;330 10.3.3.2;2. Complaints;331 10.3.3.3;3. Actions for Damages;332 10.3.3.3.1;a. Clinical Trials;332 10.3.3.3.2;b. Stillbirths;333 10.3.3.3.3;c. Pregnancy and Unwanted Births;334 10.3.3.3.4;d. Informed Consent Cases;335 10.3.3.3.5;e. Mental Injury;336 10.3.3.3.6;f. Miscellaneous;336 10.3.3.3.7;g. Exemplary Damages;336 10.3.4;Conclusion;337 10.3.4.1;A. Adequate Compensation?;337 10.3.4.2;B. Defensible Boundaries?;337 10.3.4.3;C. Administratively Efficient?;339 10.3.4.4;D. Disincentive to Safety-Conscious Behavior?;340 10.3.4.5;E. Overview;342 11;Medical Malpractice and Compensation in Poland;345 11.1;Introduction;345 11.2;I. Grounds for Civil Liability;349 11.3;II. Liability Based on Fault;362 11.4;III. Burden of Proof and Causation;369 11.5;IV. Compensation;374 11.6;V. Profes
sional Liability of Doctors;388 11.7;Conclusion;390 11.8;Addendum;391 12;Malpractice in Scandinavia;395 12.1;Introduction;395 12.2;I. The Overall Scheme for Preventing and Redressing Medical Errors and Adverse Events;397 12.2.1;A. Regulatory Methods in the Nordic Health Care Systems;397 12.2.2;B. Compensation Systems;398 12.2.3;C. Liability Systems;399 12.2.4;D. The Relationship Between the Systems;400 12.3;II. The Details of the Applicable Liability and Compensation Systems;401 12.3.1;A. Patient Injury Compensation Systems;401 12.3.1.1;1. Introduction;401 12.3.1.2;2. Basis for Compensation;401 12.3.1.2.1;a. The Experienced Specialist Standard;401 12.3.1.2.2;b. The Failure of Apparatus;403 12.3.1.2.3;c. The Alternative Treatment Rule;404 12.3.1.2.4;d. The Reasonableness Rule;404 12.3.1.2.5;e. Accidents;405 12.3.1.2.6;f. Wrong Diagnosis;406 12.3.1.2.7;g. Infection;406 12.3.1.3;3. Causation;406 12.3.1.3.1;a. The Concept of Causation in Scandinavian Law;406 12.3.1.3.2;b. The Problems of Causation in Malpractice Law;410 12.3.1.3.3;c. Relaxation of Evidence;410 12.3.1.3.4;d. Assessment of Damages;411 12.4;III. Available Empirical Data;412 12.5;Conclusion;413 13;Medical Malpractice and Compensation in South Africa;415 13.1;I. The Overall Scheme for Preventing and Redressing Medical Errors and Adverse Events, Including Regulation, Criminal and Civil Liability, and Social and Private Insurance, and the Relationships Among These Various Systems;415 13.1.1;A. Regulatory Methods;415 13.1.1.1;1. Government Licensing Authorities for Doctors and Hospitals;415 13.1.1.2;2. Medico-Ethical Codes of Conduct;419 13.1.1.3;3. Reporting of Medical Errors and Adverse Events to the Health Profession Council of South Africa;420 13.1.2;B. Liability Systems;421 13.1.2.1;1. Contract;421 13.1.2.2;2. Delict (Tort);424 13.1.2.3;3. Criminal Law;424 13.1.2.4;4. Relationship Between the Liability Systems;426 13.1.3;C. Compensation Systems;427 13.1.3.1;1. Sufficient Insurance Cover To Be Required for
Private Health Establishments;431 13.1.3.2;2. Private Indemnity (Medical Protection Society);432 13.1.4;D. Relationships Among the Compensation Systems, the Liability Systems, and the Regulatory Systems;433 13.2;II. The Details of the Applicable Liability and Compensation Systems;436 13.2.1;A. Criteria Defining Qualification for Compensation;436 13.2.1.1;1. Liability Based on Fault;436 13.2.1.2;2. The Role of the South African Constitution, 1996;438 13.2.1.3;3. Nature of Damages and Compensation;439 13.2.2;B. Causation and Loss of Chance;441 13.2.2.1;1. General Rules on Causation;441 13.2.2.2;2. Loss of a Chance;443 13.2.3;C. Liability for Failure to Obtain Informed Consent;444 13.2.4;D. Matters of Proof and Gathering of Evidence;445 13.2.4.1;1. Matters of Proof;445 13.2.4.2;a. General;445 13.2.4.3;b. Gathering of Evidence;449 13.3;III. Available Empirical Data on Medical Errors and Adverse Events, the Operation of the Systems Designed to Prevent and/or Redress such Errors and Events, and the Prevalence and Impact of Measures Designed to Reduce Medical Errors and Adverse Events, Im;450 13.4;IV. Attitudes and Concerns About the Liability and Compensation Systems;453 14;Medical Malpractice and Compensation in the UK;457 14.1;Introduction;457 14.2;I. The Context of Medical Malpractice Liability;458 14.3;II. Recent Empirical Evidence on the Numbers and Funding of Claims;460 14.3.1;A. England;460 14.3.2;B. Scotland;463 14.3.3;C. Summary;464 14.4;III. NHS Redress Act 2006;464 14.5;IV. Patients Rights Bill in Scotland: The No-Fault Compensation Review Group Report (McLean Report);466 14.6;V. Basis of Liability for Medical Injury;469 14.6.1;A. Contract, Tort, and Delict;469 14.6.2;B. The Requirements of Negligence;469 14.6.3;C. Duty of Care;470 14.6.4;D. Standard of Care;470 14.6.5;E. Causation;472 14.6.5.1;1. Difficulties in Proving Causation in Clinical Negligence Cases;473 14.6.5.2;2. The Burden of Proof;474 14.6.5.3;3. The But For Test;474 14.6.5.4;4. Cumulative Causati
on;475 14.6.5.5;5. Material Increase in Risk;475 14.6.5.6;6. Alternative Causation;475 14.6.5.7;7. Reinstating McGhee: Fairchild;476 14.6.5.8;8. The Scope of Fairchild and Clinical Negligence Cases;477 14.6.5.9;9. Loss of a Chance;480 14.7;VI. Reforming the Costs of Civil Litigation in England and Wales: Implications of the Jackson Report for the Costs of Clinical Negligence and the Ministry of Justice Reform of Legal Aid;484 14.7.1;A. Jackson Report;484 14.7.2;B. Reform of Legal Aid in England and Wales;487 14.8;Conclusion;488 15;Medical Malpractice and Compensation in Global Perspective: How Does the U.S. Do It?;491 15.1;Introduction;491 15.2;I. Details of the Applicable Regulatory and Liability/Compensation Systems;494 15.2.1;A. Regulating the Delivery of Medical Care;494 15.2.2;B. Liability/Compensation Systems;495 15.2.2.1;1. Fault-Based (Negligence);495 15.2.2.2;2. No-Fault Liability (Strict Liability);501 15.2.3;C. Limitations on Liability/Contracting out of Liability;501 15.2.4;D. Immunity from Liability;503 15.3;II. Empirical Data on Medical Errors/Adverse Events and Malpractice Litigation;504 15.3.1;A. How Common Are Medical Errors and Adverse Events?;504 15.3.2;B. Malpractice Litigation;505 15.3.2.1;1. Claiming Frequency (relative to rate of medical error/adverse events);506 15.3.2.2;2. Compensation Patterns and Time Trends;507 15.3.2.3;3. Impact of Caps on Non-Economic Damages;514 15.3.2.4;4. Accuracy of the Liability System;517 15.3.2.5;5. Frivolous Lawsuits;519 15.3.2.6;6. Cost of Medical Errors/Adverse Events;520 15.3.2.7;7. Cost of the Liability System;521 15.4;III. Attitudes and Concerns About the Liability and Compensation Systems;523 15.5;IV. Why Do Things Look the Way They Do?;524 15.6;V. What Have We Learned by Studying Texas?;525 15.6.1;A. Who Decides Malpractice Cases?;525 15.6.2;B. Does it Matter How Much the Jury Awards in a Malpractice Case?;526 15.6.3;C. How Much Coverage Do Physicians Have?;526 15.6.4;D. Do Changes in the Tort System (i.e
., increases in the number of claims, or payouts per claim) Help Explain the Malpractice Crises that Hit the United States in 20002003?;527 15.6.5;E. Impact of Tort Reforms on Claim Frequency and Payouts;528 15.7;Conclusion;528 16;Medical Malpractice and Compensation: Comparative Observations;531 16.1;Introduction;531 16.2;I. Making Sense of Diversity;534 16.2.1;A. A Diversity of Legal Mechanisms;534 16.2.1.1;1. Liability systems;534 16.2.1.2;2. Alternative compensation systems;539 16.2.1.3;3. Other regulatory and complaints mechanisms;541 16.2.2;B. The Wider Context;544 16.2.2.1;1. The substantive legal context;544 16.2.2.2;2. The wider litigation process;545 16.2.2.3;3. The health care context;548 16.2.3;C. Comparative Functional Analysis;551 16.3;II. Assessment of Liability-Based Approaches;553 16.3.1;A. Compensation;553 16.3.1.1;1. Mechanisms for dealing with organizational complexity;554 16.3.1.2;2. Adaptation of the Requirements of Causation and Proof;557 16.3.1.3;3. Patients Rights and Disclosure Duties;560 16.3.2;B. Prevention;565 16.3.2.1;1. The deterrent effect of liability rules;565 16.3.2.2;2. Pushing prevention too far? Defensive medicine and related issues;567 16.3.3;C. Accountability;568 16.3.4;D. Weighing the Evidence;569 16.3.4.1;1. Public controversy and narratives of crisis;569 16.3.4.2;2. Empirical evidence;570 16.4;III. Assessment of No-Fault Alternatives;573 16.4.1;A. Introduction;573 16.4.2;B. New Zealand: an exclusive no-fault regime;573 16.4.3;C. The Nordic Patient Insurance Schemes;575 16.4.4;D. France: Compensation on the Basis of National Solidarity;576 16.4.5;E. Comparison and Evaluation;577 16.5;Conclusion;579 17;Publications;531